Pharmaceutical manufacturer
21st Century Cures draft legislation, specifically those sections relating to regulatory and reimbursement policies affecting the biotechnology industry, and policies impacting antimicrobial product innovation.
H.R. 512, the "Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act." 
S. 145, the "Promise for Antibiotics and Therapeutics for Health Act." 
H.R. 2, the "Medicare Access and CHIP Reauthorization Act."
S. 275, the "Medicare Home Infusion Site of Care Act."
Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to implementation of the Prescription Drug User Fee program. 
Public Law No. 111-148, the "Patient Protection and Affordable Care Act," including policy and implementation issues.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FERGUSON STRATEGIES, LLC
801 Pennsylvania Ave NW, Suite 230, Washington, DC, 20004-2697, US
CHRIS JONES ADAM HIGGINS